首頁 > 市場調查報告書 > 醫療設備

市場調查報告書

商品編碼

1729047

食物過敏市場 - 全球及區域分析：依藥物類別、國家、地區 - 分析與預測（2025-2035 年）

Food Allergy Market - A Global and Regional Analysis: Focus on Drug Class, Country, and Region - Analysis and Forecast, 2025-2035

出版日期: 2025年05月21日 | 出版商:

BIS Research | 英文 100 Pages | 商品交期: 1-5個工作天內

價格

簡介目錄圖表

食物過敏發病率的上升、消費者意識的增強以及診斷和治療方法的技術進步是推動食物過敏市場成長的主要因素。

食物過敏是世界性的重大問題，影響數百萬人，導致對有效治療方案的需求日益增加。

當免疫系統將無害的食物蛋白質誤認為有害時，就會發生食物過敏。症狀從輕微到危及生命不等，凸顯了有效治療和預防措施的必要性。免疫療法和其他生技藥品的進步在改善患者預後方面發揮重要作用。

市場生命週期階段

食物過敏市場正處於發展階段，對口服免疫療法、生物製藥和基因改造產品等新治療方案進行了大量投資，旨在降低患者對過敏原的敏感度。從症狀治療到預防性護理的轉變標誌著市場生命週期的關鍵點。

全球食物過敏市場按藥物類別細分，每類藥物針對食物過敏的不同方面。抗組織胺作為治療輕微症狀的藥物很受歡迎，有助於維持穩定的市場需求。用於控制發炎的類固醇和有助於緩解呼吸道症狀的BETA2-促效劑也是重要的細分市場，由於它們在控制食物過敏症狀方面的互補作用，預計會出現適度成長。

北美佔據全球食物過敏市場的最大佔有率，其中美國貢獻巨大。

需求——促進因素與限制因素

全球食物過敏市場受以下幾個關鍵因素驅動：

全球兒童和成人食物過敏的增加可能會推動對預防和治療措施的需求
預計對研發的更多關注將極大地促進對先進過敏護理產品的需求
醫療支出和政府基礎設施投資的增加將推動食物過敏市場的成長

限制：

由於缺乏標準化的診斷標準，關於食物過敏的流行和管理的證據有限。
檢測結果的延遲和對大量血液樣本的需求（尤其是兒童的情況）可能會阻礙市場的成長。
治療期間出現嚴重副作用的風險

產品/創新策略：報告重點介紹了食物過敏治療和診斷服務的主要趨勢，以幫助公司針對食物過敏患者進行生物製藥、免疫療法和精準藥物的創新。

競爭策略：食品過敏市場競爭激烈，製藥公司、醫療保健提供者和食品製造商可以利用本報告了解市場趨勢、競爭對手和新機會，從而獲得優勢。

主要市場參與企業及競爭格局

本報告中介紹的公司是根據專家見解挑選出來的，並根據公司覆蓋範圍、產品系列和市場滲透率進行評估。全球食物過敏市場的主要企業包括製藥公司、醫療保健提供者和食品製造商。

本報告研究了全球食物過敏市場，概述了市場以及藥物類別、國家和地區的趨勢以及參與市場的公司概況。

Rising incidences of food allergies, growing awareness among consumers, and technological advancements in diagnostic and treatment methods are the primary drivers of market growth. Food allergies are a significant concern globally, affecting millions of individuals and leading to a growing demand for effective treatment options.

Food allergies occur when the immune system mistakenly identifies a harmless food protein as harmful. Symptoms can range from mild to life-threatening, highlighting the need for effective treatments and preventive measures. Advances in immunotherapy and other biologics are playing an important role in improving patient outcomes.

Market Lifecycle Stage

The food allergy market is in an evolving phase with substantial investment in new treatment options, such as oral immunotherapy, biologics, and genetically engineered products aimed at desensitizing patients to allergens. This shift from symptom management to more preventive treatments marks a pivotal point in the market's lifecycle.

Market Segmentation for the Global Food Allergy Market

Segmentation 1: by Drug Class

Epinephrine
Antihistamines
Steroids
Others

The global food allergy market is segmented by drug class, with each class addressing different aspects of food allergies. Antihistamines as a popular treatment for mild symptoms, contributing to consistent market demand. Steroids, used for managing inflammation, and Beta-2-agonists, which help alleviate respiratory symptoms, are also important segments, with moderate growth expected driven by their complementary roles in managing food allergy symptoms.

Segmentation 2: by Region

North America
Europe
Asia-Pacific

North America holds the largest share in the global food allergy market, with the U.S. being a major contributor.

Demand - Drivers and Limitations

The global food allergy market is driven by several key factors:

The global rise in food allergies among children and adults is likely to drive higher demand for preventive and therapeutic measures
A stronger focus on research and development is expected to significantly contribute to the demand for advanced allergy care products
Increased healthcare spending and government investment in infrastructure are boosting the growth of the food allergy market

Limitations:

The lack of standardized diagnostic criteria limits the evidence on food allergy prevalence and management
Delays in test results and the need for large blood samples, especially in children, can stifle market growth
Risk of severe adverse reactions during treatment

How Can This Report Add Value to an Organization?

Product/Innovation Strategy: This report highlights key trends in food allergy treatment and diagnostic services, helping companies innovate in biologics, immunotherapy, and precision medicine tailored to food allergy sufferers.

Competitive Strategy: The food allergy market is highly competitive, and pharmaceutical companies, healthcare providers, and food manufacturers can use this report to stay ahead by understanding market trends, competitors, and emerging opportunities.

Key Market Players and Competition Synopsis

The companies profiled in this report are selected based on expert insights, evaluating company coverage, product portfolio, and market penetration. Leading players in the global food allergy market include pharmaceutical companies, healthcare providers, and food manufacturers.

Executive Summary

Scope of Study

Definition

Inclusion and Exclusion Criteria

1. Global Food Allergy Market: Industry Outlook

1.1 Market Overview and Ecosystem
1.2 Epidemiological Analysis of Food Allergy
- 1.2.1 U.S.
- 1.2.2 EU5
- 1.2.3 Rest-of-the-World
1.3 Market Trends
1.4 Clinical Trials
- 1.4.1 By Phase
1.5 Regulatory Landscape Analysis
- 1.5.1 Legal Requirement and Framework in U.S.
- 1.5.2 Legal Requirement and Framework in E.U.
- 1.5.3 Legal Requirement and Framework in Asia-Pacific
- 1.5.4 Legal Requirement and Framework in Rest-of-the-World
1.6 Market Dynamics
- 1.6.1 Impact Analysis
- 1.6.2 Market Drivers
- 1.6.3 Market Restraints
- 1.6.4 Market Opportunities

2. Global Food Allergy Market, by Drug Class, $Million, 2023-2035

2.1 Epinephrine
2.2 Antihistamines
2.3 Steroids
2.4 Others

3. Global Food Allergy Market, by Region, $Million, 2023-2035

3.1 North America
- 3.1.1 Key Findings
- 3.1.2 Market Dynamics
- 3.1.3 Market Sizing and Forecast
  - 3.1.3.1 North America Food Allergy Market (by Country)
    - 3.1.3.1.1 U.S.
3.2 Europe
- 3.2.1 Key Findings
- 3.2.2 Market Dynamics
- 3.2.3 Market Sizing and Forecast
  - 3.2.3.1 Europe Food Allergy Market (by Country)
    - 3.2.3.1.1 Germany
    - 3.2.3.1.2 France
    - 3.2.3.1.3 Italy
    - 3.2.3.1.4 U.K.
3.3 Asia-Pacific
- 3.3.1 Key Findings
- 3.3.2 Market Dynamics
- 3.3.3 Market Sizing and Forecast
  - 3.3.3.1 Asia-Pacific Food Allergy Market (by Country)
    - 3.3.3.1.1 Japan

4. Global Food Allergy Market - Competitive Benchmarking and Company Profiles

4.1 Competitive Landscape
- 4.1.1 Key Strategies and Developments by Company
  - 4.1.1.1 Funding Activities
  - 4.1.1.2 Mergers and Acquisitions
  - 4.1.1.3 Regulatory Approvals
  - 4.1.1.4 Partnerships, Collaborations and Business Expansions
- 4.1.2 Key Developments Analysis
4.2 Company Profiles
- 4.2.1 Novartis Pharmaceuticals
  - 4.2.1.1 Company Overview
  - 4.2.1.2 Product Portfolio
  - 4.2.1.3 Target Customers / End Users
  - 4.2.1.4 Key Personnels
  - 4.2.1.5 Analyst View
- 4.2.2 F. Hoffmann-La Roche Ltd
  - 4.2.2.1 Company Overview
  - 4.2.2.2 Product Portfolio
  - 4.2.2.3 Target Customers / End Users
  - 4.2.2.4 Key Personnels
  - 4.2.2.5 Analyst View
- 4.2.3 DBV Technologies
  - 4.2.3.1 Company Overview
  - 4.2.3.2 Product Portfolio
  - 4.2.3.3 Target Customers / End Users
  - 4.2.3.4 Key Personnels
  - 4.2.3.5 Analyst View
- 4.2.4 Vedanta Biosciences, Inc
  - 4.2.4.1 Company Overview
  - 4.2.4.2 Product Portfolio
  - 4.2.4.3 Target Customers / End Users
  - 4.2.4.4 Key Personnels
  - 4.2.4.5 Analyst View
- 4.2.5 Regeneron Pharmaceuticals
  - 4.2.5.1 Company Overview
  - 4.2.5.2 Product Portfolio
  - 4.2.5.3 Target Customers / End Users
  - 4.2.5.4 Key Personnels
  - 4.2.5.5 Analyst View
- 4.2.6 Camallergy
  - 4.2.6.1 Company Overview
  - 4.2.6.2 Product Portfolio
  - 4.2.6.3 Target Customers / End Users
  - 4.2.6.4 Key Personnels
  - 4.2.6.5 Analyst View

5. Research Methodology

簡介目錄圖表

List of Figures

Figure: Global Food Allergy Market, Coverage
Figure: Global Food Allergy Market, Key Trends, Impact Analysis
Figure: Global Food Allergy Market, Competitive Landscape, January 2022-April 2025